Dose: 3.571 mg/kg
Single Dose: 3.6 (3.571)
Frequency: As recommended.
Route: IM
Instructions: Fortnightly

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

belongs to Androstenedione. It belongs to Antineoplastic Agent, Aromatase Inhibitor pharmacological group.The Molecular Weight of Formestane is 302.40.

Formestane is contraindicated in conditions like Premenopausal breast cancer.

The severe or irreversible adverse effects of Formestane, which give rise to further complications include Vaginal bleeding.Formestane produces potentially life-threatening effects which include Anaphylaxis. which are responsible for the discontinuation of Formestane therapy.The symptomatic adverse reactions produced by Formestane are more or less tolerable and if they become severe, they can be treated symptomatically, these include Skin reactions, Bone pain, Arthralgia, Muscle cramps, Hot flushes.

Formestane is primarily indicated in conditions like Breast cancer.

No data regarding the interactions of Formestane was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj (reconstituted susp) Store in refrigerator. Use within 24 hrs if kept at room temperature. Vial Store at room temperature.

Formestane is not recommended for use during pregnancy or lactation. Immunosuppressent drug should not be given, where possible, to patients with acute infection, dosage reduction or withdrawal should be considered if infection develops, until the infection has been controlled. Blood counts and measurement of hemoglobin concentration should be carried out routinely, it helps to predict the onset of bone marrow depression. It must be handled with great care and avoid contact with skin and eyes, and should not be inhaled.